DexCom, Inc.
DexCom, Inc. (DXCM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DXCM · as of Jun 8, 2026
Key Statistics
Explore DexCom, Inc. Data
dxcm stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 52 · Buy rate: 80.8%
The DXCM analyst consensus is Buy, based on ratings from 52 Wall Street analysts over the past 3 months. The average 12-month price target is $80.13, representing +9.98% upside from the current price of $72.86.
Competitors & Peers
dxcm competitorsDXCM
BIIB
LH
PHG
PODD
SNNStock Performance
Full HistoryAbout DexCom, Inc.
DexCom, Inc. a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company p…
what is dexcom, inc. · dxcm stock overview · dexcom, inc. company profile · who is dexcom, inc. ceo · dxcm NASDAQ · dexcom, inc. headquarters · dexcom, inc. business segments
About Stock Overview & Key Data
DexCom, Inc. (DXCM) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Apr 14, 2005. As of the latest trading session, DXCM stock price is $72.86, with a market capitalization of $28.1B. The stock has returned -14.96% over the past 12 months and +9.78% year-to-date.
According to 52 Wall Street analysts, the consensus rating for DexCom, Inc. stock is Buy, with an average 12-month price target of $80.13. In fiscal year 2025, DexCom, Inc. reported revenue of $4.7B and net income of $836.3M. For detailed data — including DexCom, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, DexCom, Inc. (DXCM) stock price is $72.86. The stock is traded on NASDAQ under the ticker symbol DXCM. The 52-week range is $54.11 – $89.98.